Browse Content by Category
Obesity
Obesity
Obesity
Obesity
Obesity
Obesity
Obesity
Obesity
Find Product Information
Explore our portfolio of products for treating obesity, including prescribing information, safety data sheets and storage and stability information.
Continuing Education
Explore accredited obesity education opportunities supported by Novo Nordisk and provided by third-party organizations.
Featured Insights and Resources
Burden of Obesity: Benefits of Weight Loss
Data showing how weight loss can improve health care costs and the risk of complications.
Overview of the STEP Clinical Development Program for Wegovy® (semaglutide) Injection
Information about Wegovy’s® STEP 1-4 clinical trials. These trials were built to evaluate its safety and efficacy for weight management in adult patients living with obesity and weight-related comorbidities.
Additional Information
Speak to a live medical representative.
If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department. If you are a patient, please visit here to contact us, or call 1-800-727-6500.
Search the Medical Information Database
The Scientific Exchange is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.
Scientific Exchange is a trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.
